ISA Saúde, a Brazilian home-hospital operator, closed a USD 30 million (BRL 160 million) Series B on 30 October 2025, led by the International Finance Corporation (IFC) with IDB Lab, Dalus Capital and Endeavor Catalyst. It matters for two reasons: this is a profitable company raising capital to acquire rather than to survive, and the lead investor is a multilateral institution whose due diligence is among the most demanding in the market.
The transaction
- Company. ISA Saúde, founded in 2019 by Fernando Parés (chief executive, an economist) and David Parés (chief medical officer, a physician); it started as Isa Lab and acquired Saúde C in 2022 (Bloomberg Línea). B2B model: it delivers hospital-level care at home, from blood testing to rehabilitation and palliative care, and bills insurers and health-plan operators.
- Instrument and amount. Series B of USD 30 million, BRL 160 million. Valuation not disclosed.
- Investors. IFC as lead investor; IDB Lab, Dalus Capital, a Mexico-based fund, and Endeavor Catalyst, alongside existing investors (Bloomberg Línea).
- Use of proceeds. Entry into Rio de Janeiro in early 2026, acquisitions of traditional home-care operators, home oncology including chemotherapy administration, and artificial intelligence applied to the patient experience. The company flagged M&A announcements for the first half of 2026.
- Status. Closed; Bloomberg Línea records it as the largest healthtech round in Latin America in 2025.
Value drivers
Profitability with growth. The company has been profitable since 2024 and reports a 98% compound annual growth rate over three years (Bloomberg Línea). That combination is rare in the region and, in our reading, explains why a multilateral institution led the round rather than a venture fund.
Measurable clinical quality. Hospital readmission below 2% against an industry average of 11%, and a cost of between 40% and 70% of traditional hospital care. For an insurer the argument is actuarial rather than technological: a lower loss ratio per case.
Payer contracts. More than 25 health-plan operators as clients, more than 1,500 daily consultations across more than 60 cities in São Paulo, Minas Gerais, Bahia and the Federal District, and more than 4,000 healthcare professionals. In our reading, the payer network is the asset a strategic buyer would pay for.
Consolidation thesis. The plan is to buy traditional home-care operators and connect them to the company’s own technology platform. The Series B price, although undisclosed, embeds an acquisition programme, not organic growth alone.
What the market is signalling
For Mexico the signal is direct. Mexican insurers are already buying home care and digital distribution: Koltin acquired Last Mile Care in April 2026 to fold in-home clinical visits into its membership, and GNP Seguros and Médica Móvil took a stake in Meddi for more than MXN 137 million in March 2026. A Mexican home-hospital operator with insurer contracts, low readmission and positive operating results now has three kinds of counterparty: venture funds, development institutions, and insurers or hospitals as strategic buyers.
For a lender, a model with contracted revenue from institutional payers and positive margins can support receivables-backed debt, something a consumer model cannot offer. For a founder, the ISA benchmark is demanding: the market rewarded profitability, auditable clinical quality and a concrete acquisition plan, not user volume.
G2’s reading for a mandate
In a round of this kind, preparation shifts its axis: the data room must prove loss ratio per case, readmissions and cost against the hospital alternative, with audited figures, before user growth. If the plan includes acquisitions, it pays to enter the process with identified targets and indicative terms, because an institutional lead investor values execution of the buy-and-build programme as much as the platform. Dalus Capital’s presence in the round shows that a Mexican fund can be the natural bridge to replicate the model in Mexico.
Sources
- LatamList (30 October 2025): ISA Saúde raises $30M Series B round led by IFC
- Bloomberg Línea (30 October 2025): La brasileña ISA Saúde recauda US$30 millones para expandir su modelo de hospital en casa
- LatamList (7 April 2026): Koltin acquires Last Mile Care
- El Financiero (11 March 2026): GNP invierte 137 mdp en Meddi